Mechanisms responsible for beneficial and adverse effects of rosiglitazone in a rat model of acute cardiac ischaemia-reperfusion
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms responsible for beneficial and adverse effects of rosiglitazone in a rat model of acute cardiac ischaemia-reperfusion
Authors
Keywords
-
Journal
EXPERIMENTAL PHYSIOLOGY
Volume 98, Issue 5, Pages 1028-1037
Publisher
Wiley
Online
2013-01-05
DOI
10.1113/expphysiol.2012.070433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Rosiglitazone on Cardiac Fibroblast Proliferation, Nitric Oxide Production and Connective Tissue Growth Factor Expression Induced by Advanced Glycation End-products
- (2013) J Li et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Rosiglitazone protects against severe hemorrhagic shock-induced organ damage in rats
- (2013) Fwu-Lin Yang et al. MEDICAL SCIENCE MONITOR
- Effects of Kaempferia parviflora Wall. Ex. Baker and Sildenafil Citrate on cGMP Level, Cardiac Function, and Intracellular Ca2+ Regulation in Rat Hearts
- (2012) Punate Weerateerangkul et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice
- (2011) Alex Morrison et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart
- (2011) Siripong Palee et al. EXPERIMENTAL PHYSIOLOGY
- Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria
- (2011) Savitree Thummasorn et al. MITOCHONDRION
- Adiponectin
- (2009) Ling Tao et al. CIRCULATION RESEARCH
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Effects of Chronic PPAR-Agonist Treatment on Cardiac Structure and Function, Blood Pressure, and Kidney in Healthy Sprague-Dawley Rats
- (2009) Eileen R. Blasi et al. PPAR Research
- Comparison of cumulative planimetry versus manual dissection to assess experimental infarct size in isolated hearts
- (2009) Matthias L. Riess et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Thiazolidinedione drugs block cardiac KATP channels and may increase propensity for ischaemic ventricular fibrillation in pigs
- (2008) L. Lu et al. DIABETOLOGIA
- Cytochrome P450 ω-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion
- (2008) Xiaojun Lv et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Different effect of acute treatment with rosiglitazone on rat myocardial ischemia/reperfusion injury by administration method
- (2008) Masahiro Abe et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A retrospective evaluation of congestive heart failure and myocardial ischemia events in 14 237 patients with type 2 diabetes mellitus enrolled in 42 short-term, double-blind, randomized clinical studies with rosiglitazone
- (2008) Alexander Cobitz et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More